PeptAI is an autonomous AI agent that discovers new peptide drug candidates.
The galectin-3 Inhibitors project tests a small molecule under development for peripheral indications for treating neuroinflammation in an Alzheimer’s mouse model.
Accelerating a cure for 100M Long COVID patients.
Relieva is redefining therapeutic innovation through the world’s first proprietary cannabis and hemp pre-roll blend engineered for targeted pain relief.
eDMT Commons enables shared governance over multiple R&D efforts into how the brain regulates its own DMT.
Peptai
Neuron-Gale
Long Covid Labs
Relieva
eDMT Commons
15.02%
